COMMUNIQUÉS West-GlobeNewswire

Auris Medical News Release

21/11/2017 - 14:01

Auris Medical to Report Third Quarter 2017 Financial Results and Provide Business Update on Tuesday, November 28, 2017 Zug, Switzerland, November 21, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage [...]

CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

21/11/2017 - 14:00

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]

Altimmune to Present at the 29th Annual Piper Jaffray Conference

21/11/2017 - 14:00

GAITHERSBURG, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today announced that Bill Enright, president and chief executive officer of Altimmune, [...]

Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]

Menlo Therapeutics Begins Phase 2 Clinical Trial for Pruritus Associated with Psoriasis

21/11/2017 - 14:00

REDWOOD CITY, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc., a late-stage biopharmaceutical company developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus ( [...]

Invuity to Present at Piper Jaffray Healthcare Conference

21/11/2017 - 14:00

SAN FRANCISCO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at [...]

TESARO Secures $500 Million Non-Dilutive Term Loan Financing

21/11/2017 - 14:00

WALTHAM, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology focused biopharmaceutical company, announced today that it has entered into a definitive term loan agreement with BIOPHARMA [...]

aTyr Pharma to Participate at the Piper Jaffray 29th Annual Healthcare Conference

21/11/2017 - 14:00

SAN DIEGO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering [...]

Ovid Therapeutics Announces Five Poster Presentations on TAK-935/OV935 at the American Epilepsy Society 71st Annual Meeting

21/11/2017 - 14:00

NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced that it [...]

New Data from Zogenix’s Phase 3 Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting

21/11/2017 - 14:00

Updated Results of Phase 2 Study of ZX008 in Lennox Gastaut Syndrome to be Presented Data Demonstrating Disease Burden and Negative Impact on Quality of Life of Patients and Families Will Also be Presented EMERYVILLE, [...]

VBL Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference

21/11/2017 - 14:00

TEL AVIV, Israel, Nov. 21, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Aclaris Therapeutics Presents New Data at American College of Rheumatology Annual Meeting For ATI-450, a MK2 pathway Inhibitor

21/11/2017 - 14:00

MALVERN, Pa., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]

Uptick Network “Stock Day” Interviews New HealthWarehouse CEO Joseph Peters on Company Success in 2017

21/11/2017 - 14:00

Florence, KY, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Uptick Network “Stock Day” interviews Joseph Peters, CEO of HealthWarehouse.com Inc. ( OTC:HEWA , the “Company” or “HealthWarehouse”) on Company success in 2017 with host [...]

Cytokinetics Announces Negative Results From VITALITY-ALS

21/11/2017 - 13:30

Phase 3 Clinical Trial of Tirasemtiv in Patients with ALS Did Not Meet Primary or Secondary Endpoints Results to be Presented December 8 th at 28th International Symposium on ALS/MND Conference Call Today at 8:30 a.m. [...]

Immunovaccine and Leidos Expand Collaboration to Develop Malaria Vaccines Formulated in DepoVax™

21/11/2017 - 13:05

HALIFAX, Nova Scotia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immunotherapy and vaccine company, today announced that it is expanding its collaboration with [...]

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Epidiolex® (cannabidiol) Data and Educational Programs at the American Epilepsy Society Annual Meeting

21/11/2017 - 13:00

LONDON, Nov. 21, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]

Deciphera Pharmaceuticals, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 13:00

WALTHAM, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH ), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today [...]

Kamada Announces New Supply Agreement with International Organization for KamRAB for Post-Exposure Prophylaxis Against Rabies Infection

21/11/2017 - 13:00

Three-Year Agreement Expected to Provide Revenues of Approximately $13 Million to Company Kamada’s Rabies Immune Globulin Recently Received FDA Approval REHOVOT, Israel, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. ( [...]

Anavex Life Sciences Reports Newly Published Data on Alzheimer's Disease Research Demonstrate the Neuroprotective Features of the Sigma-1 Receptor

21/11/2017 - 13:00

Anavex’ Sigma-1 Receptor Agonists Protect Mitochondrial Function from Amyloid Toxicity and Absence of Sigma-1 Receptor Function Exacerbates Amyloid Toxicity NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- New data published [...]